Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies

British Journal of Cancer

Volumn 85, Issue 12, 2001, Pages 1883-1886

  Moch, C ^a   Moysan, A ^a   Lubin, R ^b   De La Salmoniere P ^a   Soufir, N ^a   Galisson, F ^a   Vilmer, C ^a   Venutolo, E ^a   Le Pelletier, F ^a   Janin, A ^a   Basset Seguin N ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b Pharmacell   (France)

Author keywords

Anti p53 antibodies; Basal cell carcinomas; Skin tumours; Squamous cell carcinoma; Tumoural markers

Indexed keywords

PROTEIN ANTIBODY; PROTEIN P53; PROTEIN P53 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BASAL CELL CARCINOMA; CANCER PATIENT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODY SPECIFICITY; AUTOANTIBODIES; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENES, P53; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASMS, RADIATION-INDUCED; PROSPECTIVE STUDIES; SKIN DISEASES; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 0035556302     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.2185     Document Type: Article

References (18)

1. Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers
2. TP53 tumor suppressor gene and skin carcinogenesis
3. Mechanism involved in ultraviolet light-induced immunosuppression
4. Analysis of p53 serum antibodies in patients with head and neck squamous cell carcinoma
5. Serum anti-p53 antibodies in patients with squamous cell carcinoma of the esophagous: Comparison with p53 alterations and lymph node invasion
6. Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer
7. Apoptosis in rhumatoid arthritis. p53 overexpression in rheumatoid arthritis synovium
8. Detection and monitoring of serum p53 antibodies in patients with colorectal cancer
9. Correlations between p53-protein accumulation, serum antibodies and gene mutation in colorectal cancer
10. p53 mutations in human cancers
11. Serum p53 antibodies in patients with oral lesions: Correlation with p53/HSP70 complexes
12. Serum p53 antibodies as early markers of lung cancer
13. Prognostic significance of circulating p53 antibodies in patients undergoing surgery for locoregional breast cancer
14. Absence of p53 antibodies in sera from glioma patients
15. Human epidermal cancer and accompanying precursors have identical p53 mutations different from p53 mutations in adjacent areas of clonally expanded non-neoplasic keratinocytes
16. The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot
17. p53 antibodies in the sera of patients with various types of cancer: A review
18. Monitoring of p53 autoantibodies in lung cancer during therapy: Relationship to response to treatment